Paediatric glaucoma: Epidemiology and pathogenesis

Article

Dr Brookes explains the importance of identifying the pathogenesis in paediatric glaucoma

Paediatric glaucoma is an important but under-represented subspecialist field of glaucoma. A child diagnosed today with congenital glaucoma has a five times longer life expectancy than a patient diagnosed with primary openangle glaucoma (POAG). Therefore, the impact of a blind child to the family, society as a whole and not least to the child themselves, is immense. It is, therefore, of the utmost importance that the treatments we offer allow these children, to enjoy a sighted and independent life. The importance of this disease is shown by the fact that 18% of children in blind institutions worldwide have glaucoma and it is responsible for 5% of childhood blindness.1

Paediatric glaucoma is an intraocular-dependent disease and the prognosis depends on early, accurate diagnosis, successful control of intraocular pressure (IOP), treatment of associated ocular abnormalities, including refractive error and prevention of amblyopia. There is currently debate as to how the childhood glaucomas should be classified but generally, they can be divided into primary glaucoma, which includes 'primary congenital glaucoma' (PCG), and juvenile-onset glaucoma. Secondary glaucoma, may have a purely ocular phenotype, or be part of a systemic disease, such as a metabolic, chromosomal or connective tissue disorder.

Epidemiology

Of the children diagnosed with PCG, 94% required surgery and 75% had surgery within 4 weeks of diagnosis. The surgery of choice was either goniotomy or trabeculotomy in 87% of cases. In 50% of cases second surgery was required, 31% required 3 surgeries and 15% required 4 operations.

Of the children diagnosed with secondary glaucoma, the most frequent diagnosis was lensrelated (either aphakia or pseudophakia), 23% were secondary to the phacomatoses (most commonly SturgeWeber syndrome), 19% due to uveitis and 10% secondary to anterior segment dysgenesis. As opposed to PCG, most cases (67%) were unilateral and a lower proportion required surgery (64%).

A similar study from Toronto published in 1999 provided similar results, looking at all cases presenting to the Hospital for Sick Children over a 21year period. In this series, 98% of children with PCG required surgery and 50% of aphakic glaucoma cases required surgery, many being managed successfully with medical treatment.3

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Related Content
© 2025 MJH Life Sciences

All rights reserved.